4.3 Article

Kbtbd5 is regulated by MyoD and restricted to the myogenic lineage

期刊

DIFFERENTIATION
卷 86, 期 4-5, 页码 184-191

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.diff.2013.08.002

关键词

Kbtbd5; MRF; Myogenic lineage; Cullin 3; Myogenic differentiation

资金

  1. National Institutes of Health [5R01AR047850, 5R01AR055906]
  2. Lillehei Heart Institute

向作者/读者索取更多资源

BTB-BACK-Kelch (BBK) proteins play broad roles in cellular and molecular regulation. The role of BBK proteins in the skeletal muscle lineage and myogenesis remains an active area of research. Herein, we report a novel BBK gene, Kbtbd5, which we discovered and found to be restricted to the myogenic lineage. We observed that Kbtbd5 was absent in proliferating myoblasts and upregulated upon myogenic differentiation. In situ hybridization analysis revealed that Kbtbd5 was restricted to the skeletal muscle lineage during embryogenesis. We identified a conserved 1.2 kb upstream region, which directs reporter expression to the developing skeletal muscle lineage. Transcriptional and mutagenesis assays demonstrated that the E-box motifs contribute to the Kbtbd5 promoter activity. We have also demonstrated the in vivo and in vitro binding between MRFs and the E-box motif in the 1.2 kb promoter of the Kbtbd5 gene. Our studies have revealed that the Myod family can transactivate the 1.2 kb-luc reporter through the E-box motifs. In addition, we have shown that Kbtbd5 can recruit the Cullin 3 complex in vivo. Using shRNA knockdown, our study has revealed that Kbtbd5 plays an important role in the rnyogenic differentiation. In summary, we have demonstrated-that Kbtbd5 is the direct downstream target gene of the Myod family and regulates myogenic differentiation. Our results further support the notion that Kbtbd5 may serve as an adapter of Cul3 during myogenic differentiation. (C) 2013 International Society of Differentiation. Published by Elsevier B.V All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据